FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096828634> ?p ?o ?g. }

• W2096828634 abstract "The aim of this study was to investigate the effect of two different tapering period lengths on the concentration of plasma interleukin- 6 (IL-6), interleukin (IL-1β) and tumor necrosis factor-α (TNF-α) and performance in elite male cyclists. To this end, after completing 8 weeks progressive endurance exercise, twenty four high-level endurance cyclists were randomly assigned to one of two groups: a control group of cyclists (n = 12) continued performing progressive weekly training volume for 3 weeks while a taper group of cyclists (n = 12) proceeded with a 50% reduction in weekly training volume relative to the control group. A simulated 40 min time trial (40TT) performance ride was used as the criterion index of performance before and after the tapering period to evaluate the physiological and performance effects of each protocol. Blood samples were collected immediately post-40TT from all participants at the beginning of week 1, and the end of weeks 4, 8, 9 and 11. IL-1β, IL-6 and TNFα were assayed using a standard commercial ELISA kits (Quantikine; R & D Systems, Minneapolis, MN). The mean time to complete the 40TT in the taper group decreased significantly (p < 0.01) after both 1 and 3 weeks with reduced training volume relative to the control group. There were significant reductions in (p < 0.001) IL-1β, IL-6 and TNFα concentrations in the taper group relative to the control group at the end of the 3 week tapering period, but not at the end of the 1 week tapering period. These results demonstrate that both a 1 and a 3 week taper period will result in improved physical performance in trained cyclists but only a 3 week taper period will result in attenuation of post-exercise pro- inflammatory cytokines when compared to those continuing a more intense training regimen. Key pointsThe excessive endurance exercise-induced elevations in pro-inflammatory cytokines would, in turn, stimulate the release of anti-inflammatory cytokines.Elevations in pro-inflammatory cytokines indicate athletes are highly susceptible to infections.1and 3-week taper periods will reduce circulating pro-inflammatory cytokine levels thereby possibly limiting the chances of infection and potentially reducing the effects of these cytokines in inducing fatigue-like symptoms in athletes." @default.
• W2096828634 created "2016-06-24" @default.
• W2096828634 creator A5029805232 @default.
• W2096828634 creator A5031162180 @default.
• W2096828634 creator A5037221584 @default.
• W2096828634 date "2009-01-01" @default.
• W2096828634 modified "2023-09-27" @default.
• W2096828634 title "The effect of tapering period on plasma pro-inflammatory cytokine levels and performance in elite male cyclists." @default.
• W2096828634 cites W119104324 @default.
• W2096828634 cites W1912560002 @default.
• W2096828634 cites W1981697720 @default.
• W2096828634 cites W1998254273 @default.
• W2096828634 cites W2000345169 @default.
• W2096828634 cites W2000590093 @default.
• W2096828634 cites W2004940262 @default.
• W2096828634 cites W2016586685 @default.
• W2096828634 cites W2019898900 @default.
• W2096828634 cites W2023038436 @default.
• W2096828634 cites W2031019767 @default.
• W2096828634 cites W2040281761 @default.
• W2096828634 cites W2044982368 @default.
• W2096828634 cites W2045830093 @default.
• W2096828634 cites W2048488935 @default.
• W2096828634 cites W2093845352 @default.
• W2096828634 cites W2103488083 @default.
• W2096828634 cites W2111805231 @default.
• W2096828634 cites W2119524953 @default.
• W2096828634 cites W2121115208 @default.
• W2096828634 cites W2124139079 @default.
• W2096828634 cites W2129023649 @default.
• W2096828634 cites W2131292893 @default.
• W2096828634 cites W2137853718 @default.
• W2096828634 cites W2156241207 @default.
• W2096828634 cites W2157554312 @default.
• W2096828634 cites W2172013173 @default.
• W2096828634 cites W2285204915 @default.
• W2096828634 cites W1606363524 @default.
• W2096828634 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3761545" @default.
• W2096828634 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24149602" @default.
• W2096828634 hasPublicationYear "2009" @default.
• W2096828634 type Work @default.
• W2096828634 sameAs 2096828634 @default.
• W2096828634 citedByCount "9" @default.
• W2096828634 countsByYear W20968286342014 @default.
• W2096828634 countsByYear W20968286342015 @default.
• W2096828634 countsByYear W20968286342016 @default.
• W2096828634 countsByYear W20968286342019 @default.
• W2096828634 countsByYear W20968286342020 @default.
• W2096828634 countsByYear W20968286342021 @default.
• W2096828634 countsByYear W20968286342023 @default.
• W2096828634 crossrefType "journal-article" @default.
• W2096828634 hasAuthorship W2096828634A5029805232 @default.
• W2096828634 hasAuthorship W2096828634A5031162180 @default.
• W2096828634 hasAuthorship W2096828634A5037221584 @default.
• W2096828634 hasConcept C114138010 @default.
• W2096828634 hasConcept C121684516 @default.
• W2096828634 hasConcept C126322002 @default.
• W2096828634 hasConcept C140793950 @default.
• W2096828634 hasConcept C1862650 @default.
• W2096828634 hasConcept C2777953023 @default.
• W2096828634 hasConcept C2780310989 @default.
• W2096828634 hasConcept C41008148 @default.
• W2096828634 hasConcept C71924100 @default.
• W2096828634 hasConcept C84393581 @default.
• W2096828634 hasConcept C86803240 @default.
• W2096828634 hasConceptScore W2096828634C114138010 @default.
• W2096828634 hasConceptScore W2096828634C121684516 @default.
• W2096828634 hasConceptScore W2096828634C126322002 @default.
• W2096828634 hasConceptScore W2096828634C140793950 @default.
• W2096828634 hasConceptScore W2096828634C1862650 @default.
• W2096828634 hasConceptScore W2096828634C2777953023 @default.
• W2096828634 hasConceptScore W2096828634C2780310989 @default.
• W2096828634 hasConceptScore W2096828634C41008148 @default.
• W2096828634 hasConceptScore W2096828634C71924100 @default.
• W2096828634 hasConceptScore W2096828634C84393581 @default.
• W2096828634 hasConceptScore W2096828634C86803240 @default.
• W2096828634 hasLocation W20968286341 @default.
• W2096828634 hasLocation W20968286342 @default.
• W2096828634 hasOpenAccess W2096828634 @default.
• W2096828634 hasPrimaryLocation W20968286341 @default.
• W2096828634 hasRelatedWork W1993431822 @default.
• W2096828634 hasRelatedWork W2029001390 @default.
• W2096828634 hasRelatedWork W2031019767 @default.
• W2096828634 hasRelatedWork W2095811170 @default.
• W2096828634 hasRelatedWork W2096828634 @default.
• W2096828634 hasRelatedWork W2116813625 @default.
• W2096828634 hasRelatedWork W2157338832 @default.
• W2096828634 hasRelatedWork W2161297287 @default.
• W2096828634 hasRelatedWork W2411613724 @default.
• W2096828634 hasRelatedWork W3164405091 @default.
• W2096828634 isParatext "false" @default.
• W2096828634 isRetracted "false" @default.
• W2096828634 magId "2096828634" @default.
• W2096828634 workType "article" @default.